The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats

Pötsch, Mareike S, Tschirner, Anika, Palus, Sandra, von Haehling, Stephan, Doehner, Wolfram, Beadle, John, Coats, Andrew, Anker, Stefan D and Springer, Jochen (2014) The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats. Journal of Cachexia, Sarcopenia and Muscle, 5 (2). pp. 149-158. ISSN 2190-5991

Full text not available from this repository.

Abstract

Sarcopenia, the age-related, progressive loss of skeletal muscle mass, strength, and function, is a considerable socioeconomic burden by increasing risks of falls, fractures, and frailty. Moreover, sarcopenic patients are often obese and therapeutic options are very limited.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology
Depositing User:	Pure Connector
Date Deposited:	24 Jan 2014 12:42
Last Modified:	24 Oct 2022 05:48
URI:	https://ueaeprints.uea.ac.uk/id/eprint/46779
DOI:	10.1007/s13539-013-0125-7

Actions (login required)

View Item